73
Active Trials
23
Phase 1
11
Phase 2
36
Phase 3
10
Therapeutic Areas
Portfolio Concentration: 62% of active trials in Metabolic
Metabolic
45 active / 367 total
Cardiovascular
9 active / 16 total
Immunology
7 active / 18 total
Rare Disease
3 active / 8 total
Renal
2 active / 9 total
CNS
2 active / 3 total
Oncology
1 active / 3 total
Musculoskeletal
1 active / 1 total
Urology
0 active / 11 total
Endocrine
0 active / 8 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)